Newsfeed : Medical Marijuana and the KS Connection

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » August 2007

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

August 1, 2007

Medical Marijuana and the KS Connection

People with HIV who use marijuana products for nausea, pain or appetite problems associated with HIV and HIV meds may have been alarmed to hear this morning’s news from researchers at Harvard Medical School that the drug may encourage Kaposi’s sarcoma (KS). The findings are so preliminary, however, that no one’s suggesting new warnings about medical marijuana yet.

You may remember KS, the skin cancer that was a prime AIDS-defining illness in the 1980s—and whose hallmark purple lesions were an unforgettable visual marker of HIV’s deadly first decade. Antiretroviral drugs have virtually knocked it out, but the Kaposi’s sarcoma herpes virus (KSHV) can still cause the disease among people with extremely compromised immune systems.

The Harvard study, published in the August 1st issue of Cancer Research and funded by the National Institutes of Health, determined that low doses of THC, the active ingredient in marijuana and the prescription medication Marinol (dronabinol), stimulates proteins on endothelial cells in the body’s skin and other tissues. This, the test tube study suggests, allows KSHV to enter the cells and begin reproducing.  

Connecting the study findings to real-world use of pot or Marinol is a leap the scientists have not yet made, however. “We still do not know the exact molecular events that are occurring here,” according to lead study author Jerome E. Groopman, M.D., professor of medicine at Harvard Medical School. “These results are just the first part of our ongoing research.”


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Are you buying holiday gifts that raise HIV/AIDS awareness?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.